This measurement has been shown to be proportional to the BM exit rate. Indeed, newly developed BM leukocytes transit from the BM parenchyma through the endothelium and into the BM sinusoids where they are transiently retained until their release into the blood circulation. Results presented in Fig. 4B showed that the percentage Proteasome inhibitor of sinusoidal Ly6C− monocytes was significantly decreased in the BM of S1pr5−/− or Ccr2−/− mice compared to the BM of WT mice. By contrast, the

percentage of sinusoidal Ly6C− monocytes was significantly increased in the BM of Cx3Cr1gfp/gfp mice compared to the BM of WT mice. These results support a role for S1PR5 in the migration of Ly6C− monocytes from the parenchyma to the sinusoidal compartment of the BM, a process essential for exit from the BM. This process could be negatively regulated by CX3CR1, perhaps as a result of adhesive properties of CX3CR1. Second, we compared the fate of monocytes of different genotypes adoptively transferred into recipient mice. We performed intravenous injection of a 1:1 mixture of WT (CD45.1) and S1pr5−/− or Cx3cr1gfp/gfp (CD45.2) BM cells into recipient WT (CD45.1 × CD45.2) mice. Sixteen hours after transfer, we measured the frequency of donor monocyte subsets in the blood and the www.selleckchem.com/products/gsk2126458.html BM of recipient mice. We calculated the ratio between WT and KO donors for each subset before transfer and 16 h after transfer in the blood

and the BM. Cx3cr1gfp/gfp Ly6C− monocytes were barely detectable in both BM and blood of recipient mice, confirming the important role of CX3CR1

in the survival of Ly6C− monocytes (Fig. 4C, left panel). By contrast, transferred S1pr5−/− Ly6C− monocytes were almost absent from the blood but were represented at similar frequency as WT Ly6C− monocytes in the BM of recipient mice (Fig. 4C, right panel). These data support a role for S1PR5 in the egress of Ly6C− monocytes rather than in their survival. Third, we compared the ex vivo viability of WT and S1pr5−/− Ly6C− monocytes in the blood and BM of WT S1pr5−/−chimeric mice using AnnexinV/7-AAD staining. In both compartments, the viability of S1pr5−/− Ly6C− monocytes was slightly lower than that of WT Ly6C− monocytes (Fig. 4D). Moreover, irrespective of the mouse genotype, the viability of Ly6C− monocytes was lower in the BM than in the blood. We also assessed viability of WT and S1pr5−/− Astemizole Ly6C− monocytes sorted by flow cytometry and cultured in the presence or absence of M-CSF. After 24 h, the viability of WT and S1pr5−/− Ly6C− monocytes was similar in both culture conditions (Fig. 4E). Finally, we measured the expression of Bcl2, an important anti-apoptotic molecule that has been shown to be down regulated in Cx3cr1gfp/gfp Ly6C− monocytes and to regulate their survival. The expression of Bcl2 was similar in Ly6C− monocytes from WT and S1pr5−/− mice but it was reduced in Cx3cr1gfp/gfp Ly6C− monocytes (Fig. 4F), as previously reported [21].